“Treatments for hypersensitive noncarious cervical lesions: a Practitioners Engaged in Applied Research and Learning (PEARL) Network randomized clinical effectiveness study.”, J Am Dent Assoc, vol. 144, no. 5, pp. 495-506, 2013.
, “Treatments for Hypersensitive Noncarious Cervical Lesions: A Practitioners Engaged in Applied Research and Learning (PEARL) Network Randomized Clinical Effectiveness Study”, J Am Dent Assoc, vol. 144, pp. 495-506, 2013.
, “Optical Coherence Tomography Reflective Drusen Substructures Predict Progression to Geographic Atrophy in Age-related Macular Degeneration.”, Ophthalmology, vol. 123, no. 12, pp. 2554-2570, 2016.
, , “Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine.”, PLoS One, vol. 5, no. 1, p. e8617, 2010.
, “Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine.”, PLoS One, vol. 5, no. 1, p. e8816, 2010.
, “Phase 1 Safety and Immunogenicity Evaluation of ADVAX a Multigenic, DNA-Based Clade C/B’ HIV-1 Candidate Vaccine”, PLoS ONE, vol. 5, p. e8617, 2010.
, “In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers.”, PLoS One, vol. 6, no. 5, p. e19252, 2011.
, “Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 Clade B'/C Candidate Vaccine”, PLOS One, vol. 5, p. e8816, 2010.
, “Cellular and Humoral Immunogenicity of ADMVA, a Clade C/B MVA-Based HIV-1 Candidate Vaccine, in Healthy Volunteers”, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
, “PedsQL™ Cognitive Functioning Scale in Pediatric Liver Transplant Recipients: Feasibility, Reliability, and Validity”, Qual Life Res, vol. 20, pp. 913-921, 2011.
, “PedsQL™ Cognitive Functioning Scale in pediatric liver transplant recipients: feasibility, reliability, and validity.”, Qual Life Res, vol. 20, no. 6, pp. 913-21, 2011.
, “A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Vaccine Based on Adeno-Associated Virus”, AIDS Res Hum Retroviruses, vol. 26, pp. 933-942, 2010.
, “Safety and Immunogenicity of MVA.HIVA by 3 Different Routes”, in AIDS Vaccine 2005 International Conference, Montreal, Quebec, Canada, 2005.
, “A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant Adeno-Associated Virus HIV Vaccine”, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
, “A phase 2 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 vaccine based on adeno-associated virus.”, AIDS Res Hum Retroviruses, vol. 26, no. 8, pp. 933-42, 2010.
, “Predictors of Agreement Between Hair Analysis and Self-Report of Drug Use”, in 77th Annual Meeting of the College on Problems of Drug Dependence (CPDD), Phoenix, AZ, 2015.
, “Seroincidence of human T-lymphotropic virus type I infection and characterization of seroconverters in Jamaican food handlers.”, J Acquir Immune Defic Syndr, vol. 33, no. 3, pp. 387-92, 2003.
, “Seroincidence of HTLV-I infection and characterization of seroconverters in Jamaican food handlers”, J Acquir Immune Defic Syndr, vol. 33, pp. 387-392, 2003.
, “Evaluation of Predictive Markers of HTLV-I Associated Disease in Jamaica”, in The 12th International Conference on Human Retrovirology: HTLV and Related Viruses, Montego Bay, Jamaica, 2005.
, “Outcome of Renal Transplantation for Wilms' Tumor and Denys-Drash Syndrome: A Report of the North American Pediatric Renal Transplant Cooperative Study”, Pediatr Transplant, vol. 9, pp. 305-310, 2005.
, “Outcome of renal transplantation for Wilms' tumor and Denys-Drash syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study.”, Pediatr Transplant, vol. 9, no. 3, pp. 305-10, 2005.
, “Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection.”, AIDS, vol. 12, no. 4, pp. 433-7, 1998.
, “Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection”, AIDS, vol. 12, pp. 433-7, 1998.
, “No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No.”, Ophthalmology, vol. 126, no. 11, pp. 1541-1548, 2019.
,